ArticleOncoimmunology2020

Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model.

Pravin T P Kaumaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.